Drug class
Calcium replacement agent; intravenous electrolyte and membrane-stabilising salt
Mechanism of action
Provides ionised calcium required for excitation-contraction coupling and neuromuscular transmission. In severe hyperkalaemia, calcium stabilises the cardiac myocyte membrane and reduces immediate arrhythmia risk but does not lower serum potassium.
General use cases
- Treatment of acute symptomatic hypocalcaemia
- Cardiac membrane stabilisation in severe hyperkalaemia with electrocardiographic changes, and in selected calcium-channel-blocker toxicity protocols
- Calcium replacement in selected emergency settings; route and dose must follow product-specific IV safety instructions
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
